Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer

Overview of attention for article published in Journal of Clinical Pathology, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 40 X posts from 27 X users, with an upper bound of 86,179 followers.

RT @JClinPath_BMJ: Discover the fascinating world of non-telomerase Alternative Lengthening of Telomeres (ALT) in cancers. @Chris_Heaphy an…

RT @JClinPath_BMJ: Discover the fascinating world of non-telomerase Alternative Lengthening of Telomeres (ALT) in cancers. @Chris_Heaphy an…

Discover the fascinating world of non-telomerase Alternative Lengthening of Telomeres (ALT) in cancers. @Chris_Heaphy and colleagues shed light on ALT's prevalence and vital role in cancers: https://t.co/bwKSoz520h #CancerResearch #ALT #Telomeres therape

RT @SimonAprilMonn: Great stuff by 𝑡ℎ𝑒 𝑜𝑛𝑒 & 𝑜𝑛𝑙𝑦 "𝐀𝐋𝐓𝐢𝐭𝐨𝐧𝐚𝐧𝐭" @Chris_Heaphy ... who discovered #ALT in @Neuroendocrine #cancer and functio…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 36 additional X posts.